Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05165940 · ClinicalTrials.gov registry record · NA
Facilitating Transition to Recommended PTSD Treatment
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05165940: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT05165940 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05165940, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Cognitive processing therapy (CPT) and prolonged exposure therapy (PE) were widely disseminated as recommended posttraumatic stress disorder (PTSD) treatments. However, post-9/11 Veterans with PTSD rarely initiate CPT or PE, especially as an initial treatment. Little research has explored the combinations and sequences of psychosocial and medication treatments that Veterans receive ("treatment sequences"). One common and understudied treatment sequence begins with stabilization treatment, which is designed to prepare Veterans for CPT or PE. There is a significant research gap in understanding how treatment sequence affects initiation of CPT or PE. The proposed research is an innovative, mixed-methods approach to assessing the impact of variability in treatment sequence, including stabilization treatment, on initiation of CPT or PE and applying this knowledge by developing a health services intervention that facilitates timely transition to CPT or PE. Research aims can improve PTSD treatment by increasing initiation of and reducing disparities in CPT/PE.
Interventions
- BEHAVIORAL Treatment As Usual
- BEHAVIORAL New Health Services Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2027-05-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05165940
The ClinicalTrials.gov registry entry for NCT05165940 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment As Usual is the first listed.
NCT05165940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05165940 about?
NCT05165940 is a clinical study titled "Facilitating Transition to Recommended PTSD Treatment". Cognitive processing therapy (CPT) and prolonged exposure therapy (PE) were widely disseminated as recommended posttraumatic stress disorder (PTSD) treatments. However, post-9/11 Veterans with PTSD rarely initiate CPT or PE, especially as an initial treatment. Little research has explored the combin...
What is the current status of trial NCT05165940?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-08-01. Estimated completion is 2027-05-03.
What interventions are being tested in trial NCT05165940?
The interventions under investigation include: Treatment As Usual (BEHAVIORAL), New Health Services Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05165940?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.